Product Images Decitabine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Decitabine NDC 68083-528 by Gland Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
decitabine-spl-carton-label - decitabine spl carton label
Decitabine for Injection is a cytotoxic agent used for intravenous infusion only. The package contains a single sterile vial with a concentration of 50 mg per vial, and the final solution has 5 mg/mL concentration and pH of 6.7 to 7.3. To maintain stability, leftover diluted solution should be refrigerated and used within 4 hours of reconstitution. Further dilution is required and should be done using cold infusion fluid. The package insert contains detailed information on dosage, indications, and precautions. Storage temperature should be kept between 20°C to 25°C. The product is manufactured by Gland Pharma Limited in India. The National Drug Code is 68083-528-01.*
decitabine-spl-structure - decitabine spl structure
decitabine-spl-vial-label - decitabine spl vial label
This text seems to contain multiple snippets of information, some of which are incomplete or disordered. However, it appears to be related to a pharmaceutical product called "Decitabine for Injection" that is intended for intravenous infusion. The text also includes a warning regarding the product being a cytotoxic agent and some instructions on how to use and discard the vial after use. There are also some other alphanumeric codes and measurements that are not clear and seem unrelated.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.